Selective AXL inhibitors
Bergen, Norway, 17 February 2021 – In this Radium podcast interview with RADFORSK, BerGenBio CEO Richard Godfrey gives an overview of BerGenBio’s research so far and the expected milestones in 2021.
Listen to the podcast here: https://soundcloud.com/user-972208711/episode-164
Please remember to confirm your email by clicking on the link provided in the subscription confirmation email. We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.
